Just how much of a difference does it make to order exome sequencing first?
For patients with seizures, there’s a real difference between ordering exome sequencing first and starting with a multi-gene panel or chromosomal microarray (CMA).
For patients with seizures, there’s a real difference between ordering exome sequencing first and starting with a multi-gene panel or chromosomal microarray (CMA).
This Epilepsy Awareness Month, we’re shining light on the genetic causes of seizures.
Findings from the first 4,000 newborns screened using GeneDx genome sequencing, were published today in the Journal of the American Medical Association (JAMA).
Ben’s illness started with seizures when he was just six-months old.
His mother, Ashley, never stopped searching for answers—and finally found them with a genome test.
Leveraging our expansive genomic database, we’re working to transform care for pediatric patients. See GeneDx research being presented at the American Association of Human Genetics Annual Meeting.